Evidence browser
Explore the evidence
Loading the evidence…
Evidence browser
Loading the evidence…
Evidence browser
35,999 claims
CQC will review the use of restraint, segregation and prolonged seclusion in settings for people with mental health issues.
The Secretary of State for Health and Social Care has asked CQC to carry out a review of the use of restraint, segregation and prolonged seclusion in settings that accommodate people with mental health problems, a learning disability or autism.
Operational · Procedural statement · From Monitoring the Mental Health Act: 2017 to 2018 — Monitoring the Mental Health Act in 2017 to 2018, page 6
The Long Term Plan for the NHS includes capital investment to upgrade mental health ward environments.
We welcome the statement in the Long T erm Plan that capital investment from the forthcoming Spending Review will be made available to upgrade the physical environment for inpatient psychiatric care.
Commissioning · Policy statement · From Monitoring the Mental Health Act: 2017 to 2018 — Monitoring the Mental Health Act in 2017 to 2018, page 6
There is a high use of restrictive interventions on mental health wards, with significant variation between wards.
We have highlighted the high use of restrictive interventions on mental health wards (and the great variation in use between wards),
Service · Observational claim · From Monitoring the Mental Health Act: 2017 to 2018 — Monitoring the Mental Health Act in 2017 to 2018, page 6
Many mental health wards are unsafe and provide poor quality care, which is a major concern.
However, it is important that this does not mask the fact that many of the wards, in which people are detained under the MHA, are unsafe and provide poor quality care.
Service · Observational claim · From Monitoring the Mental Health Act: 2017 to 2018 — Monitoring the Mental Health Act in 2017 to 2018, page 6
There has been improvement in care planning and patient involvement despite rising demand.
This report shows improvement in the aspects of practice that are the focus of our work to monitor the use of the Mental Health Act (MHA). In particular, we have seen improvement in the quality of care planning and how patients are involved in their care.
Service · Observational claim · From Monitoring the Mental Health Act: 2017 to 2018 — Monitoring the Mental Health Act in 2017 to 2018, page 6
The 2017-2018 report highlights the possibility for improvement in mental health services despite budget pressures and rising demand.
The 2017 to 2018 report shows that at a time of pressure on budgets and rising demand, improvement is still possible in mental health services.
Strategic · Observational claim · From Monitoring the Mental Health Act: 2017 to 2018, [page]
CQC conducts visits to assess the provision of medical treatment and support for patients under the Mental Health Act.
To inform the report, CQC carries out visits to check how mental health services are providing medical treatment to people detained under the MHA and are supporting patients to recover.
Operational · Procedural statement · From Monitoring the Mental Health Act: 2017 to 2018, [page]
CQC's annual report examines how providers care for patients under the Mental Health Act.
The Care Quality Commission’s (CQC) annual report on the use of the Mental Health Act (MHA) looks at how providers are caring for patients, and whether patients’ rights are being protected.
Service · Policy statement · From Monitoring the Mental Health Act: 2017 to 2018, [page]
NHS England plans to use the findings to further reduce unnecessary prescription of psychotropic drugs.
NHS England want to use these numbers to stop more people with learning disabilities or autism from being given these medicines when they don’t need them.
Policy · Commitment statement · From Psychotropic drugs and people with learning disabilities or autism — Psychotropic drugs and people with learning disabilities or autism: easy-read summary, page 5
It may take a long time to see significant changes in prescription patterns due to the slow process of reducing medication.
It can take a long time to take someone off medication. So we might have been looking too soon to see a big difference.
Context · Observational claim · From Psychotropic drugs and people with learning disabilities or autism — Psychotropic drugs and people with learning disabilities or autism: easy-read summary, page 5
The study examined GP records from 2010 to 2017 for people with learning disabilities, autism, or both.
We looked at how many people with learning disabilities, autism or both were given these medicines. We looked at numbers from 2010 to 2017.
Research · Procedural statement · From Psychotropic drugs and people with learning disabilities or autism — Psychotropic drugs and people with learning disabilities or autism: easy-read summary, page 3
NHS England initiated the STOMP programme to reduce unnecessary prescription of psychotropic drugs.
NHS England wants to stop these medicines being given to people when they won’t help. They started a programme called STOMP to make this happen.
Policy · Policy statement · From Psychotropic drugs and people with learning disabilities or autism — Psychotropic drugs and people with learning disabilities or autism: easy-read summary, page 3
The unnecessary prescription of psychotropic drugs can be due to challenging behavior or self-harm.
Some people are given these when others find their behaviour challenging or because they do things to hurt themselves.
Context · Observational claim · From Psychotropic drugs and people with learning disabilities or autism — Psychotropic drugs and people with learning disabilities or autism: easy-read summary, page 2
People with learning disabilities, autism, or both may be prescribed psychotropic drugs unnecessarily.
People with learning disabilities, autism or both are sometimes given medicines they don’t need.
Context · Observational claim · From Psychotropic drugs and people with learning disabilities or autism — Psychotropic drugs and people with learning disabilities or autism: easy-read summary, page 2
Following the launch of STOMP, changes in GP prescribing of psychotropic drugs for adults with learning disabilities were observed.
Even with the limited data points, the study showed that, following the launch of STOMP, changes to GP prescribing of psychotropic drugs were beginning to happen in the desired direction for adults with learning disabilities.
Service · Observational claim · From Psychotropic drugs and people with learning disabilities or autism, [page]
Other similar data sources are available and can be used with the methods developed in this study.
Other similar data sources are available and the methods used in this study could be applied to them.
Service · Procedural statement · From Psychotropic drugs and people with learning disabilities or autism, [page]
The conclusions of the study were limited due to a short period and reduced population coverage.
The conclusions from the study were limited due to the short period of time and a reducing population coverage towards the end of the time period studied.
Research · Risk statement · From Psychotropic drugs and people with learning disabilities or autism, [page]
The methods used in the study can be applied to monitor trends in prescribing rates and patterns of psychotropic drugs.
The methods used in this study could be used to monitor the trends in prescribing rates and patterns of psychotropic drugs prescribed by GPs for people with learning disabilities, autism or both.
Service · Procedural statement · From Psychotropic drugs and people with learning disabilities or autism, [page]
Data about the use of psychotropic drugs between January 2010 and December 2017 was provided.
It provides data about the extent and trends in the use of psychotropic drugs between January 2010 and December 2017.
Metric · Observational claim · From Psychotropic drugs and people with learning disabilities or autism, [page]
The study was commissioned by NHS England to monitor the impact of their programme to reduce overmedication for people with learning disabilities or autism.
This study was commissioned by NHS England to devise a method to report the impact of their programme to stop overmedication for people with learning disabilities, autism or both (STOMP).
Commissioning · Policy statement · From Psychotropic drugs and people with learning disabilities or autism, [page]